RenaissanceRe Expands Cat Bond Business With $340M Medici UCITS Fund

Zacks
06 Mar

RenaissanceRe Holdings Ltd. RNR recently introduced a new property catastrophe bond fund called RenaissanceRe Medici UCITS Fund, which is registered in Ireland. This fund is designed to give European and global investors access to RenaissanceRe’s catastrophe bond investment strategy within a European-regulated UCITS structure. The Central Bank of Ireland is regulating Medici UCITS.

The new fund is an extension of the company’s existing RenaissanceReMedici Fund Ltd., following similar investment principles. At 2024-end, RNR had 15.8% noncontrollingeconomic ownership in the Medici entity.

The fund started with $340 million in capital, including $140 million co-invested by RNR. While the fund is not expected to be consolidated into its financial statements, it will generate fee income, and RNR’s investment in it will be recorded at fair value.

This move aligns with RenaissanceRe’s broader strategy of expanding globally, diversifying capital sources and strengthening its investment platform. With the new fund, the company is aiming to connect with more European and global investors. This allows the company to attract more third-party capital, diversifying its investor base beyond traditional markets.

RNR’s Capital Partners team will serve as the investment manager for the fund. They highlighted 25-year success in managing third-party capital and building strong investor relationships. The move is expected to strengthen its catastrophe bonds business, helping them match capital with risk efficiently while also creating a stable revenue stream. By leveraging its risk expertise and deep experience in alternative capital management, RNR is well-positioned to generate consistent returns.

RNR’s Price Performance

Shares of RenaissanceRe have gained 7% in the past year compared with a 15.7% rise of the industry it belongs to.


Image Source: Zacks Investment Research

Zacks Rank & Key Picks

RenaissanceRe currently has a Zacks Rank #3 (Hold).

Some better-ranked players in the broader Finance space are ProAssurance Corporation PRA, HCI Group, Inc. HCI and Palomar Holdings, Inc. PLMR, each presently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The consensus mark for ProAssurance’s bottom line for 2025 is pegged at 91 cents per share. The stock has witnessed two upward estimate revisions in the past 30 days with no movement in the opposite direction. PRA beat earnings estimates in each of the last four quarters, with an average surprise of 152.7%.

The Zacks Consensus Estimate for HCI Group’s 2025 earnings per share indicates 102.2% year-over-year growth to $14.98. It beat earnings estimates in each of the last four quarters, with an average surprise of 45.7%. The consensus mark for HCI’s current-year revenues signals a 17.5% increase from a year ago.

The Zacks Consensus Estimate for Palomar Holdings’ 2025 earnings per share projects 31.8% year-over-year growth to $6.71. It beat earnings estimates in each of the last four quarters, with an average surprise of 16.6%. The consensus mark for PLMR’s current-year revenues signals 38.9% growth from a year ago.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RenaissanceRe Holdings Ltd. (RNR) : Free Stock Analysis Report

ProAssurance Corporation (PRA) : Free Stock Analysis Report

HCI Group, Inc. (HCI) : Free Stock Analysis Report

Palomar Holdings, Inc. (PLMR) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10